BNY Mellon

KEYCORP ANNOUNCES RETIREMENT OF VERNON PATTERSON, DIRECTOR OF INVESTOR RELATIONS; BRIAN MAUNEY JOINS KEY AS SUCCESSOR

Retrieved on: 
Wednesday, January 10, 2024
KeyBank, CCAR, Strategic management, BNY Mellon, Citigroup

CLEVELAND, Jan. 10, 2024 /PRNewswire/ -- KeyCorp (NYSE:KEY) announced that Vernon Patterson, Director of Investor Relations, will retire in the spring of 2024, and will be succeeded by Brian Mauney, effective March 1.

Key Points: 
  • CLEVELAND, Jan. 10, 2024 /PRNewswire/ -- KeyCorp (NYSE:KEY) announced that Vernon Patterson, Director of Investor Relations, will retire in the spring of 2024, and will be succeeded by Brian Mauney, effective March 1.
  • "I am pleased to welcome Brian to Key as our Director of Investor Relations," Chris continued.
  • "Brian brings a depth and variety of financial services experience to the role that I am excited to add to the organization."
  • Brian, who has more than 25 years of experience in the financial services industry, previously served as the Deputy Director of Investor Relations at BNY Mellon, including responsibility for their Fixed Income Investor Relations program.

The Wall Street Technology Association (WSTA) is Pleased to Welcome Helene Sing, Head of Enterprise Change Governance and Integration, to its 2024 Board of Directors

Retrieved on: 
Wednesday, January 10, 2024
UBS, Safe, Project management, Enterprise, Policy, Bank, Business administration, Software craftsmanship, Information system, Woman, CSCP, Supply chain management, Integration, PSM, PMP, McKinsey & Company, WSTA, Johnson & Johnson, Bank of America, RTE, Drexel University, BNY Mellon, PSPO, Management

NEW YORK, Jan. 10, 2024 /PRNewswire-PRWeb/ -- The Wall Street Technology Association (WSTA®), a not-for-profit financial services organization that provides technology and business professionals a forum to learn from and connect with each other, is pleased to welcome Helene Sing, Head of Enterprise Change Governance and Integration, BNY Mellon, to its 2024 Board of Directors.

Key Points: 
  • The Wall Street Technology Association (WSTA®), a not-for-profit financial services organization that provides technology and business professionals a forum to learn from and connect with each other, is pleased to welcome Helene Sing, Head of Enterprise Change Governance and Integration, BNY Mellon, to its 2024 Board of Directors.
  • NEW YORK, Jan. 10, 2024 /PRNewswire-PRWeb/ -- The Wall Street Technology Association (WSTA®) , a not-for-profit financial services organization that provides technology and business professionals a forum to learn from and connect with each other, is pleased to welcome Helene Sing, Head of Enterprise Change Governance and Integration, BNY Mellon, to its 2024 Board of Directors.
  • At BNY Mellon, Helene Sing is responsible for defining and embedding policy, governance, controls, training, and tools for change/transformation initiatives across the company.
  • Her prior roles at BNY Mellon include Head of Enterprise Portfolio Management and Head of Technology Change Integration Governance.

Evaxion Announces Plan to Implement ADS Ratio Change

Retrieved on: 
Monday, January 8, 2024
Depository Trust Company, ADS, Tax, Bank, Sale, DKK, Effective date, Ratio, DTC, Depositary, BNY Mellon, American depositary receipt, DRS, Security (finance)

COPENHAGEN, Denmark, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that it plans to change the ratio of its American Depositary Shares (“ADSs”) to its ordinary shares, DKK 1 nominal value (the “ADS Ratio”), from the current one (1) ADS representing one (1) ordinary share to a new ADS Ratio of one (1) ADS representing ten (10) ordinary shares (the “ADS Ratio Change”).

Key Points: 
  • COPENHAGEN, Denmark, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that it plans to change the ratio of its American Depositary Shares (“ADSs”) to its ordinary shares, DKK 1 nominal value (the “ADS Ratio”), from the current one (1) ADS representing one (1) ordinary share to a new ADS Ratio of one (1) ADS representing ten (10) ordinary shares (the “ADS Ratio Change”).
  • The ADS Ratio Change is expected to become effective on or about January 22, 2024, U.S. Eastern Time (the “Effective Date”).
  • For the Company’s ADS holders, the change in the ADS Ratio will have the same effect as a one-for-ten reverse ADS split and is intended to further support the liquidity in the Company’s ADSs and to enable the Company to regain compliance with the Nasdaq minimum bid price requirement.
  • As a result of the ADS Ratio Change, the ADS trading price is expected to increase proportionally, although the Company can give no assurance that the ADS trading price after the ADS Ratio Change will be proportionally equal to or greater than the previous ADS trading price prior to the change or that the Ratio Change will have any effect on the liquidity in the Company’s ADSs.

Renesas Extends Tender Offer for Proposed Acquisition of Sequans

Retrieved on: 
Friday, January 5, 2024
ADS, Bank, Letter, CFIUS, Electronics, BNY Mellon, American depositary receipt

Shareholders to Receive U.S. $0.7575 per Ordinary Share and U.S. $3.03 per ADS in cash

Key Points: 
  • Tokyo, Japan and Paris, France--(Newsfile Corp. - January 5, 2024) - Renesas Electronics Corporation (TSE: 6723) ("Renesas") and Sequans Communications S.A. (NYSE: SQNS) ("Sequans") today announced that Renesas has extended the expiration date of its tender offer to acquire all of the outstanding ordinary shares of Sequans for $0.7575 per ordinary share and American Depositary Shares ("ADSs") of Sequans for $3.03 per ADS (each ADS representing four ordinary shares) in cash, without interest and less any applicable withholding taxes.
  • The tender offer, which was previously scheduled to expire at one minute after 11:59 P.M., New York City time, on January 5, 2024, has been extended until one minute after 11:59 P.M., New York City time, on January 22, 2024, unless the tender offer is further extended or earlier terminated.
  • The tender offer was extended to allow additional time for the satisfaction of the remaining closing conditions of the tender offer, including, but not limited to, regulatory approvals (other than the previously announced CFIUS approval, NSIA approval and Taiwan merger control approval) and the valid tender of ordinary shares and ADSs of Sequans representing - together with ordinary shares and ADSs of Sequans beneficially owned by Renesas, if any - at least 90% of the fully diluted ordinary shares of Sequans.
  • The Bank of New York Mellon, the Tender Agent for the tender offer, has advised Renesas that as of 6 p.m., New York City time, on January 4, 2024, approximately 116,333,513 ordinary shares of Sequans (including ordinary shares represented by ADSs), representing approximately 41.9% of the fully diluted ordinary shares of Sequans, have been validly tendered and not properly withdrawn pursuant to the tender offer.

Webinar Invite: Introducing a Revolutionary Labor Actions Dashboard

Retrieved on: 
Thursday, January 4, 2024
School, Select Medical, Hospital, News, BNY Mellon, Taco Bell, Data mining

Labor actions impact millions daily.

Key Points: 
  • Labor actions impact millions daily.
  • It compares this information with already logged actions, and presents new actions for review and logging through Megaputer's integrated BI platform.
  • Additional value that Megaputer’s Labor Action Tracker provides:
    The webinar educates attendees on how to effectively use the dashboard to stay ahead of the mass and make informed decision with the help of the following deliverables:
    Comprehensive Insights: Access the latest US labor data through Megaputer's innovative dashboard, providing a nuanced view of key dynamics.
  • Join us for the unveiling of Megaputer’s Labor Action Tracker by registering for the webinar below:
    Unable to attend?

Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink

Retrieved on: 
Thursday, January 4, 2024
Science, Other Science, Research, ADS, Thermo Fisher Scientific, Sales management, Bank, TMO, DNB ASA, Letter, BNY Mellon, American depositary receipt, Security (finance)

The Offer is being made pursuant to the Purchase Agreement, dated as of October 17, 2023, by and between Thermo Fisher and Olink.

Key Points: 
  • The Offer is being made pursuant to the Purchase Agreement, dated as of October 17, 2023, by and between Thermo Fisher and Olink.
  • The Offer is now scheduled to expire at 5:00 p.m., New York time, on February 29, 2024, unless the Offer is extended or earlier terminated.
  • These Shares and ADSs collectively represent approximately 94.1% of the outstanding Shares as of such time.
  • Olink shareholders who have already tendered their Shares or ADSs of Olink do not have to re-tender their Shares or ADSs or take any other action as a result of the extension of the expiration time of the Offer.

BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) Announces Distribution

Retrieved on: 
Wednesday, January 3, 2024
Asset Management, Professional Services, Finance, BNY, NAV, Bank, BNY Mellon, Policy, Fund, DMB, Newsroom, BNY Mellon Investment Management, BK, Security (finance)

BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) today announced a distribution of $0.0300 per share of common stock, payable on February 1, 2024 to shareholders of record at the close of business on January 19, 2024.

Key Points: 
  • BNY Mellon Municipal Bond Infrastructure Fund, Inc. (NYSE: DMB) today announced a distribution of $0.0300 per share of common stock, payable on February 1, 2024 to shareholders of record at the close of business on January 19, 2024.
  • BNY Mellon Investment Management is one of the world’s largest asset managers, with $1.8 trillion in assets under management as of September 30, 2023.
  • Through a client-first approach, BNY Mellon Investment Management brings investors specialist expertise through its seven investment firms offering solutions across every major asset class and backed by the breadth and scale of BNY Mellon.
  • BNY Mellon Investment Management is a division of BNY Mellon, which has $45.7 trillion in assets under custody and/or administration as of September 30, 2023.

Renesas Extends Tender Offer for Proposed Acquisition of Sequans

Retrieved on: 
Tuesday, December 19, 2023
ADS, Bank, Letter, CFIUS, Electronics, BNY Mellon, American depositary receipt

Shareholders to Receive U.S. $0.7575 per Ordinary Share and U.S. $3.03 per ADS in cash

Key Points: 
  • Tokyo, Japan and Paris, France--(Newsfile Corp. - December 19, 2023) - Renesas Electronics Corporation (TSE: 6723) ("Renesas") and Sequans Communications S.A. (NYSE: SQNS) ("Sequans") today announced that Renesas has extended the expiration date of its tender offer to acquire all of the outstanding ordinary shares of Sequans for $0.7575 per ordinary share and American Depositary Shares ("ADSs") of Sequans for $3.03 per ADS (each ADS representing four ordinary shares) in cash, without interest and less any applicable withholding taxes.
  • The tender offer, which was previously scheduled to expire at one minute after 11:59 P.M., New York City time, on December 20, 2023, has been extended until one minute after 11:59 P.M., New York City time, on January 5, 2024, unless the tender offer is further extended or earlier terminated.
  • The tender offer was extended to allow additional time for the satisfaction of the remaining closing conditions of the tender offer, including, but not limited to, regulatory approvals (other than the previously announced CFIUS approval, NSIA approval and Taiwan merger control approval) and the valid tender of ordinary shares and ADSs of Sequans representing - together with ordinary shares and ADSs of Sequans beneficially owned by Renesas, if any - at least 90% of the fully diluted ordinary shares of Sequans.
  • The Bank of New York Mellon, the Tender Agent for the tender offer, has advised Renesas that as of 6 p.m., New York City time, on December 18, 2023, approximately 104,685,461 ordinary shares of Sequans (including ordinary shares represented by ADSs), representing approximately 37.5% of the fully diluted ordinary shares of Sequans, have been validly tendered and not properly withdrawn pursuant to the tender offer.

Renesas Extends Tender Offer and Receives Taiwan Merger Control Approval for Proposed Acquisition of Sequans

Retrieved on: 
Tuesday, December 5, 2023
ADS, Bank, Letter, Acquisition, CFIUS, Electronics, BNY Mellon, American depositary receipt

Shareholders to Receive U.S. $0.7575 per Ordinary Share and U.S. $3.03 per ADS in cash

Key Points: 
  • The tender offer, which was previously scheduled to expire at one minute after 11:59 P.M., New York City time, on December 6, 2023, has been extended until one minute after 11:59 P.M., New York City time, on December 20, 2023, unless the tender offer is further extended or earlier terminated.
  • The tender offer was extended to allow additional time for the satisfaction of the remaining closing conditions of the tender offer, including, but not limited to, regulatory approvals (other than the Taiwan merger control approval and the previously announced NSIA approval and CFIUS approval) and the valid tender of ordinary shares and ADSs of Sequans representing - together with ordinary shares and ADSs of Sequans beneficially owned by Renesas, if any - at least 90% of the fully diluted ordinary shares of Sequans.
  • The Bank of New York Mellon, the Tender Agent for the tender offer, has advised Renesas that as of 6 p.m., New York City time, on December 4, 2023, approximately 108,974,617 ordinary shares of Sequans (including ordinary shares represented by ADSs), representing approximately 38.8% of the fully diluted ordinary shares of Sequans, have been validly tendered and not properly withdrawn pursuant to the tender offer.
  • Holders that have previously tendered their shares do not need to re-tender their shares or take any other action in response to this extension.

Renesas Extends Tender Offer for Proposed Acquisition of Sequans

Retrieved on: 
Monday, November 20, 2023
ADS, Bank, Letter, CFIUS, Electronics, BNY Mellon, American depositary receipt

Shareholders to Receive U.S. $0.7575 per Ordinary Share and U.S. $3.03 per ADS in cash

Key Points: 
  • Tokyo, Japan and Paris, France--(Newsfile Corp. - November 20, 2023) - Renesas Electronics Corporation (TSE: 6723) ("Renesas") and Sequans Communications S.A. (NYSE: SQNS) ("Sequans") today announced that Renesas has extended the expiration date of its tender offer to acquire all of the outstanding ordinary shares of Sequans for $0.7575 per ordinary share and American Depositary Shares ("ADSs") of Sequans for $3.03 per ADS (each ADS representing four ordinary shares) in cash, without interest and less any applicable withholding taxes.
  • The tender offer, which was previously scheduled to expire at one minute after 11:59 P.M., New York City time, on November 21, 2023, has been extended until one minute after 11:59 P.M., New York City time, on December 6, 2023, unless the tender offer is further extended or earlier terminated.
  • The tender offer was extended to allow additional time for the satisfaction of the remaining closing conditions of the tender offer, including, but not limited to, regulatory approvals (other than the previously announced CFIUS approval and NSIA approval) and the valid tender of ordinary shares and ADSs of Sequans representing - together with ordinary shares and ADSs of Sequans beneficially owned by Renesas, if any - at least 90% of the fully diluted ordinary shares of Sequans.
  • The Bank of New York Mellon, the Tender Agent for the tender offer, has advised Renesas that as of 6 p.m., New York City time, on November 17, 2023, approximately 109,035,233 ordinary shares of Sequans (including ordinary shares represented by ADSs), representing approximately 38.8% of the fully diluted ordinary shares of Sequans, have been validly tendered and not properly withdrawn pursuant to the tender offer.